Evolving strategies for the use of combination therapy in hypertension (Q34824876)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Evolving strategies for the use of combination therapy in hypertension	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Evolving strategies for the use of combination therapy in hypertension (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

author name string

Alan H Gradman

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

Celso Acevedo

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

publication date

1 October 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

published in

Current Hypertension Reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

volume

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

page(s)

343-349

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

cites work

Characteristics of patients with uncontrolled hypertension in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diuretic therapy for hypertension and the risk of primary cardiac arrest

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maximizing Cardiorenal Benefit in the Management of Hypertension: Achieve Blood Pressure Goals

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12217251

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11906-002-0062-X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

Dimensions Publication ID

1025625706

0 references

PubMed publication ID

12217251

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12217251

retrieved

4 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34824876&oldid=2197057826"